- Home
- BYND vs VOR Comparison
BYND vs VOR Comparison
Compare BYND & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYND
- VOR
- Stock Information
- Founded
- BYND 2009
- VOR 2015
- Country
- BYND United States
- VOR United States
- Employees
- BYND N/A
- VOR N/A
- Industry
- BYND Packaged Foods
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- BYND Consumer Staples
- VOR Health Care
- Exchange
- BYND Nasdaq
- VOR Nasdaq
- Market Cap
- BYND 214.6M
- VOR 207.1M
- IPO Year
- BYND 2019
- VOR 2021
- Fundamental
- Price
- BYND $1.04
- VOR $9.92
- Analyst Decision
- BYND Sell
- VOR Buy
- Analyst Count
- BYND 7
- VOR 6
- Target Price
- BYND $1.70
- VOR $80.67
- AVG Volume (30 Days)
- BYND 427.2M
- VOR 894.1K
- Earning Date
- BYND 11-10-2025
- VOR 11-13-2025
- Dividend Yield
- BYND N/A
- VOR N/A
- EPS Growth
- BYND N/A
- VOR N/A
- EPS
- BYND N/A
- VOR N/A
- Revenue
- BYND $290,565,000.00
- VOR N/A
- Revenue This Year
- BYND N/A
- VOR N/A
- Revenue Next Year
- BYND $0.27
- VOR N/A
- P/E Ratio
- BYND N/A
- VOR N/A
- Revenue Growth
- BYND N/A
- VOR N/A
- 52 Week Low
- BYND $0.50
- VOR $2.62
- 52 Week High
- BYND $7.69
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- BYND 40.25
- VOR 22.17
- Support Level
- BYND $0.94
- VOR $9.00
- Resistance Level
- BYND $1.23
- VOR $10.50
- Average True Range (ATR)
- BYND 0.21
- VOR 1.62
- MACD
- BYND -0.03
- VOR -1.50
- Stochastic Oscillator
- BYND 9.93
- VOR 5.73
About BYND Beyond Meat Inc.
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.